[A new synthetic coagulation inhibitor. Only half as many thromboembolisms].
D017326:Clinical Trials, Phase III as Topic; D000077425:Fondaparinux; D006622:Hip Prosthesis; D006801:Humans; D007720:Knee Prosthesis; D011134:Polysaccharides / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D016896:Treatment Outcome
D011134:Polysaccharides; D000077425:Fondaparinux